ARCA BIOPHARMA ANNOUNCES POSITIVE OUTCOME OF END-OF-PHASE 2 MEETING WITH FDA ON GENCARO DEVELOPMENT FOR ATRIAL FIBRILLATION Posted on July 31, 2018 by ARCA IT - Press Release, Uncategorized End of Phase 2 FDA meeting - FINAL